MedTrace Logo

Turmeric for Memory Impairment and Cognition

NCT04860050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 568

Last updated 2024-01-18

No results posted yet for this study

Summary

The objective of the study is to test the capacity of acute and chronic supplementations of Turmipure GOLD® to improve cognitive performance in healthy aging

Conditions

  • Cognitive Change
  • Mood
  • Stress

Interventions

DIETARY_SUPPLEMENT

Turmipure Gold®

TPG: Turmipure GOLD® - 1 capsule per day - as prescribed

DIETARY_SUPPLEMENT

Placebo

Placebo: colored acacia gum - 1 capsule per day - as prescribed

Sponsors & Collaborators

  • Atlantia Food Clinical Trials

    collaborator INDUSTRY

  • Givaudan France Naturals

    lead INDUSTRY

Principal Investigators

  • Timothy Dinan, Professor · Atlantia Food Clinical Trials

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2023-08-10
Completion
2023-08-10

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04860050 on ClinicalTrials.gov